According to Arcadia Biosciences's latest financial reports the company's total assets are $19.7 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $28.92 M | -34.15% |
2021-12-31 | $43.91 M | -7.24% |
2020-12-31 | $47.34 M | 45.36% |
2019-12-31 | $32.57 M | 35.59% |
2018-12-31 | $24.02 M | 44.98% |
2017-12-31 | $16.57 M | -70.71% |
2016-12-31 | $56.57 M | -23.8% |
2015-12-31 | $74.24 M | 198.29% |
2014-12-31 | $24.88 M | 160.84% |
2013-12-31 | $9.54 M | -28.57% |
2012-12-31 | $13.35 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Marrone Bio Innovations
MBII | N/A | N/A | ๐บ๐ธ USA |
Codexis
CDXS | $0.13 B | 593.03% | ๐บ๐ธ USA |
ScottsMiracle-Gro SMG | $3.71 B | 18,758.67% | ๐บ๐ธ USA |
American Vanguard AVD | $0.76 B | 3,795.19% | ๐บ๐ธ USA |